Genotype and severity of long QT syndrome

Drug Metabolism and Disposition

Volumn 29, Issue 4 II, 2001, Pages 574-579

  Towbin, J A ^a   Wang, Z ^a   Li, H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MEXILETINE; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM SPARING DIURETIC AGENT; SODIUM CHANNEL;

AUTOMATIC CARDIOVERSION; AUTOSOMAL RECESSIVE DISORDER; CONFERENCE PAPER; DISEASE SEVERITY; GENE MUTATION; GENOTYPE; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HUMAN; LONG QT SYNDROME; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYMPATHECTOMY;

CHROMOSOME MAPPING; GENOTYPE; HUMANS; LONG QT SYNDROME; PHENOTYPE;

MUSTELA VISON;

EID: 0035056820     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Kr potassium channels with HERG and is associated with cardiac arrhythmia
2. + channel activity through interactions between alpha- and beta 1-subunits
3. Ks cardiac potassium current
4. An analysis of the time-relationship of electrocardiograms
5. Molecular mechanism for an inherited cardiac arrhythmia
6. Kr and trafficking in long QT syndrome
7. Right bundle-branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report
8. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
9. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
10. Multiple mechanisms of sodium channel-linked long QT syndrome
11. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients
12. Novel mechanism associated with an inherited cardiac arrhythmia. Defective protein in trafficking by the mutant HERG (G60IS) potassium channel
13. Two long QT syndrome loci map to chromosome 3 and 7 with evidence for further heterogeneity
14. Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel
15. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene
16. New mutations in the KVLQT1 potassium channel that cause long QT syndrome
17. Long QT syndrome associated with syndactyly identified in females
18. Kr
19. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome
20. Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome
21. + channels
22. A novel mutation on the potassium channel gene KVLQT1 causes the Jervell and Lange-Neilsen cardioauditory syndrume
23. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management (Parts I and II)
24. Low penetrance in the long-QT syndrome. Clinical impact
25. A recessive variant of the Romano-Ward long-QT syndrome
26. QT-interval prolongation, paroxysmal ventricular arrhythmias, and convulsive syncope
27. Ks potassium channel
28. Kr potassium channel
29. Mapping of a gene for long QT syndrome to chromosome 4q25-27
30. The long-QT syndrome
31. The long QT syndrome
32. + channel blockade and to increases in heart rate
33. Prolongation of the QT Interval and the Sudden Infant Death Syndrome
34. Brief report: Molecular basis of the long-QT syndrome associated with deafness
35. Ks function
36. Prolongation of the long QT syndrome and Sudden Infant Death syndrome
37. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: Analysis of 23 families
38. Molecular biology of arrhythmic syndromes
39. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
40. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
41. + channel
42. The congenital long QT syndromes in children
43. + channel mutations found in inherited cardiac arrhythmias
44. Influence of the genotype on the clinical course of the long-QT syndrome